SCHEMBL10242201

SCHEMBL10242201

NS(=O)(=O)OC[C@H]1CC[C@H](n2cnc3c(NCc4ccc(Cl)cc4)ncnc32)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.49
▸ ADORA3 P0DMS8 4/20 0.43
▸ ADORA2A P29274 4/20 0.43
▸ ADORA1 P30542 3/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CCNA2 P20248 3/20 0.42
▸ CDK2 P24941 3/20 0.42
▸ CDK5 Q00535 3/20 0.42
▸ CDK5R1 Q15078 3/20 0.42
▸ CCNT1 O60563 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ CCNB1 P14635 1/20 0.42
▸ CDK7 P50613 1/20 0.42
▸ CDK9 P50750 1/20 0.42
▸ CCNH P51946 1/20 0.42
▸ MNAT1 P51948 1/20 0.42
▸ ADCY5 O95622 5/20 0.42
▸ SLC29A1 Q99808 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10233932 0.88 CA2 (0.46) CTSL
SCHEMBL192286 0.84 NAE1 (0.54) CTSLADORA3ADORA2AADORA1
SCHEMBL12567124 0.82 ABL1 (0.49) CTSLADORA3NPC1RAB9ASMN1; SMN2
SCHEMBL13192031 0.79 NAE1 (0.44) CCNA2CDK2CDK5CDK5R1
SCHEMBL10293821 0.79 NAE1 (0.51) CTSLNPC1RAB9ASMN1; SMN2
SCHEMBL2740595 0.78 METTL3 (0.49) ADORA3ADORA2AADORA1CCNA2CDK2
SCHEMBL1794568 0.78 SLC29A1 (0.64) ADORA3ADORA2AADORA1SLC29A1
SCHEMBL10293817 0.77 NAE1 (0.44) —
SCHEMBL2740570 0.76 NAE1 (0.44) ADORA3SMN1; SMN2
SCHEMBL13191975 0.76 NAE1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402334-A1 Inhibitors of E1 Activating Enzymes Millennium Pharmaceuticals, Inc. (US) 2012-01-04 — — EP disclosed
Send feedback